SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs
Article in Acta Pharmacologica Sinica (January 2024)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Article in Acta Pharmacologica Sinica (January 2024)
Article in Breast Cancer Research (January 2024)
Article in Clinical Breast Cancer (September 2023)